Luvaminos

Cortagen

A synthetic tetrapeptide (Ala-Glu-Asp-Pro) studied in non-clinical models as a short-peptide bioregulator in brain-cortex, peripheral-nerve and gene-expression research systems.

Quick answers

What is Cortagen?

Cortagen is a synthetic linear tetrapeptide of 4 amino acids with a molecular weight of 430.41 g/mol and the formula C17H26N4O9.

How much published research cites Cortagen?

The Luvaminos Cortagen record cites 9 published references, dated 2000 to 2021. Each is listed on this page with a link to its source.

Does Luvaminos test Cortagen, and where is the certificate?

Luvaminos does not currently stock Cortagen. Every peptide lot Luvaminos sells is tested by Freedom Diagnostics Testing, PLLC, an independent laboratory, and its certificate is published at luvaminos.com/coa under the lot number printed on the vial.

How is Cortagen powder stored?

Sealed Cortagen powder: Store sealed and protected from light, frozen (−20 °C, or colder for long-term storage), and desiccated. As a small unmodified linear tetrapeptide of common L-amino acids with two acidic residues, Cortagen would be expected to be susceptible to proteolysis and to degradation from heat, light and repeated freeze–thaw.

Molecular Profile

Type
Synthetic linear tetrapeptide
Molecular formula
C17H26N4O9
Molecular weight
430.41 g/mol
CAS number
335591-03-2
Amino acids
4
Sequence
Ala-Glu-Asp-Pro (AEDP); systematic form H-Ala-Glu-Asp-Pro-OH
Modification
Unmodified free N-/C-termini

Mechanism & Target Class

Cortagen belongs to the Khavinson class of short regulatory peptides, sequences of 2–7 amino acid residues proposed to act as epigenetic modulators by entering cell nuclei and interacting with DNA and histone proteins rather than through classical receptor engagement; the class framework is reviewed by Vanyushin & Khavinson (2016) and Khavinson et al. (2021). Cortagen-specific mechanistic data in the verified literature are at the transcript and tissue-response level. A cDNA microarray study (Anisimov, Khavinson & Anisimov, 2004) screened 15,247 transcripts in the hearts of female CBA mice given Cortagen for five consecutive days and reported 234 clones (1.53% of those screened) with significant expression changes, matching 110 known genes across functional categories, with common and peptide-specific effects when compared with Vilon, Epitalon and melatonin. In organotypic cultures, Cortagen stimulated the growth of explants from rat brain cortex, whereas peptides matched to other tissues stimulated their own tissue's explants, which the author described as tissue-specific action (Khavinson, 2001). A direct Cortagen-DNA or Cortagen-chromatin binding study was not identified in the sources reviewed.

Storage & Handling

Lyophilized
Store sealed and protected from light, frozen (−20 °C, or colder for long-term storage), and desiccated.
Handling
As a small unmodified linear tetrapeptide of common L-amino acids with two acidic residues, Cortagen would be expected to be susceptible to proteolysis and to degradation from heat, light and repeated freeze–thaw; no formal pharmacokinetic study measuring the intact peptide was identified in the verified literature.

Primary Database

PubChem CID 18439621 ↗

References (9)

  1. Reviews

    1

    Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR (2021). Molecules

    DOI: 10.3390/molecules26227053PubMed 34834147

  2. 2

    Vanyushin BF, Khavinson VK (2016). Epigenetics – A Different Way of Looking at Genetics (Springer)

    DOI: 10.1007/978-3-319-27186-6_5

  3. Primary research

    3

    Anisimov SV, Khavinson VKh, Anisimov VN (2004). Neuro Endocrinology Letters

    PubMed 15159690

  4. 4

    Kolosova LI, Moiseeva AB, Turchaninova LN, Malinin VV (2002). Doklady Biological Sciences

    DOI: 10.1023/A:1016098302564PubMed 12134478

  5. 5

    Khavinson VK (2001). Bulletin of Experimental Biology and Medicine

    DOI: 10.1023/A:1013058701974PubMed 11713572

  6. 6

    Turchaninova LN, Kolosova LI, Malinin VV, Moiseeva AB, Nozdrachev AD, Khavinson VK (2000). Bulletin of Experimental Biology and Medicine

    DOI: 10.1023/A:1017532001908PubMed 11276314

  7. 7

    Zarubina IV, Shabanov PD (2011). Eksperimental'naia i Klinicheskaia Farmakologiia

    PubMed 21476278

  8. 8

    Shabanov PD, Vislobokov AI (2013). Reviews on Clinical Pharmacology and Drug Therapy

    DOI: 10.17816/RCF11217-25

  9. 9

    Kuznik BI, Pateiuk AV, Baranchugova LM, Rusaeva NS (2008). Advances in Gerontology

    PubMed 19432169

Related compounds

About Cortagen

What is Cortagen?

Cortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) studied in non-clinical models as a short-peptide bioregulator in brain-cortex, peripheral-nerve and gene-expression research systems.

What are the molecular formula, molecular weight and CAS number of Cortagen?

Cortagen: molecular formula C17H26N4O9, molecular weight 430.41 g/mol and CAS number 335591-03-2.

What is the sequence of Cortagen?

Ala-Glu-Asp-Pro (AEDP); systematic form H-Ala-Glu-Asp-Pro-OH.

How is Cortagen powder stored?

Store sealed and protected from light, frozen (−20 °C, or colder for long-term storage), and desiccated.